riluzole has been researched along with Agranulocytosis in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 63-year-old woman with amyotrophic lateral sclerosis (ALS) presented with nausea, anorexia, and fever two weeks following inadvertent dose escalation of riluzole from 100 to 200 mg/d." | 3.70 | Reversible granulocytopenia in association with riluzole therapy. ( Khan, AM; North, WA; Sporn, JR; Yamase, HT, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| North, WA | 1 |
| Khan, AM | 1 |
| Yamase, HT | 1 |
| Sporn, JR | 1 |
1 other study available for riluzole and Agranulocytosis
| Article | Year |
|---|---|
Reversible granulocytopenia in association with riluzole therapy.
Topics: Agranulocytosis; Amyotrophic Lateral Sclerosis; Female; Humans; Middle Aged; Neuroprotective Agents; | 2000 |